Osteopathy Chicago Ltd. – Trademark Portfolio
Entity Type: 03
Osteopathy Chicago Ltd. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 5 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include QUANTUMTIDE HYPNOSIS, QUANTUMTIDE BREATHWORK, and QUANTUMTIDE OSTEOPATHY. The owner is based in Chicago, IL.
111 N. Wabash Ave. Suite 712
Chicago, IL 60602
Showing of trademarks Trademarks
Trademark Classifications
Osteopathy Chicago Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Osteopathy Chicago Ltd. have?
Osteopathy Chicago Ltd. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.
What trademark classes does Osteopathy Chicago Ltd. file in?
Osteopathy Chicago Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 41 (Education & Entertainment). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Osteopathy Chicago Ltd.'s most well-known trademarks?
Osteopathy Chicago Ltd.'s registered trademark portfolio includes well-known marks such as QUANTUMTIDE HYPNOSIS, QUANTUMTIDE BREATHWORK, and QUANTUMTIDE OSTEOPATHY. These are among 4 currently registered trademarks in the portfolio.
What is Osteopathy Chicago Ltd.'s trademark registration success rate?
Osteopathy Chicago Ltd. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.